From: Understanding a mass in the paraspinal region: an anatomical approach
WHO | Clinical signs | US signs Method of choice for superficial tumours | CT signs Method of choice for calcifications and bone analysis | MRI signs Method of choice for soft tissue and bone | Relative frequency in the back |
---|---|---|---|---|---|
Adipocytic tumours | Â | Â | Â | Â | Â |
Lipoma | 40–60 y Mobile Grows with weight gain Multiples (mostly in the back) | Hyperechoic Fine hyperechoic lines Compressible | HU in the negative range | Follows subcutaneous fat signal No nodule No septation No enhancement | Common in upper back |
Liposarcoma | 40–70 y | Lipoma with atypical features: Hypervascularity Hypoechoic areas | HU in the negative range Calcification | Variable amount of fat content Lipoma with atypical features: nodule/septa /enhancement | Uncommon* |
Hibernoma | 20–40 y |  | Attenuation | Flow voids | Exceptional |
PNST | Â | Â | Â | Â | Â |
BPNST | 30–60 y Pain Multiples | – | Foramen enlargement | Dumbbell shape Split-fat sign (T1WI) Tail sign (T1WI) Target sign (T2WI) Fascicular sign (T2WI) | Common |
Plexiform neurofibromas | 15–30 y Consistency like a «bag of worms» History of NF1 | Superficial Multiloculated Cutaneous and subcutaneous Hypoechoic foci | – | Infiltrative appearance Target sign (T2WI) | Rare |
MPNST | 30–60 y Pain Numbness Paresthesia NF1 | – | Foramen enlargement Bone lysis | Large size Heterogeneous signal Perilesional oedema No split-fat sign | Rare |
Fibro/myofibroblastic tumours | Â | Â | Â | Â | Â |
Desmoid tumour | 25–45 y F > M Trauma Rapidly growing Pain Multiples | Fascia based lesion Hypoechoic Staghorn sign Fascial tail sign | – | Tail sign Band sign Temporal change with time hypointense on all sequence | Common |
Solitary fibrous tumour | 40–60 y | – | Prominent feeding vessels | Prominent feeding vessels Avid enhancement | Rare |
Myxofibrosarcoma | 50–70 y | – | – | Water-like appearance (T2WI) Tail sign | Rare |
Vascular tumours | Â | Â | Â | Â | Â |
Haemangioma | 20–30 y Painful Physical exertion Fluctuating daily size | Heterogeneous Hypoechoic with multiple cysts Augmentation of out flow by compression Augmentation of in flow by release | Phleboliths | Fat content (T1WI) Serpentine vascular structures Atrophic changes in muscles | Uncommon |
Angiosarcoma | 60–70 y | – | – | Heterogeneous Vessels (high or low flow) Foci of haemorrhages | Exceptional* |
Myogenic tumours | Â | Â | Â | Â | Â |
Leiomyoma | – | – | – | – | Exceptional |
Rhabdomyosarcoma | < 20 y | – | – | – | Exceptional |
Leiomyosarcoma | 50–70 y | – | Contiguous with a vessel | Contiguous with a vessel | Rare* |
Chondro-osseous tumours | Â | Â | Â | Â | Â |
Chondro-osseous tumours | 30–60 y | – | Chondroid matrix: arc and ring-like calcifications Bone matrix | Chondroid matrix: High T2 signal | Exceptional |
Tumours with uncertain differentiation | Â | Â | Â | Â | Â |
Myxoma | 30–60 y F > M | Fatty bright cap sign Aligned in muscle fibre axis | – | Fluid-like signal intensity Aligned in muscle fibre axis | Uncommon |
Undifferentiated pleomorphic sarcoma | 50–75 y | – | – | – | Rare |
Synovial sarcoma | 15–40 y | – | Calcification | Triple sign (T2WI) Internal haemorrhage | Rare |
Muscle metastasis | 50–70 y History of cancer | – | Multiple Rim enhancement Central attenuation | Rim enhancement | Common |